Based on information in the 2018 annual report and outstanding shares as of 9/3/19, I'm calculating the company still owes Gerald 6,568,104 of AMBS common stock related to board-approved exchange rates on Series E and H preferred stock.
(1)
(1)
Amarantus Bioscience Holdings (AMBS) Stock Research Links